Shared on 05 Nov 25
Fair value Decreased 0.64%Analysts have slightly reduced their fair value estimate for Prio by $0.36 to $55.86. This reflects a modest recalibration as expectations for revenue growth and discount rate ease, and profit margins trend upward.
Shared on 21 Oct 25
Fair value Decreased 2.12%Analysts have slightly reduced their price target for Prio to $56.21 from $57.43. This adjustment reflects updated views on revenue growth, profit margins, and sector trends highlighted in recent research.
Shared on 23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 1.31%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 0.56%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 8.45%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 9.56%AnalystConsensusTarget has decreased future PE multiple from 9.9x to 8.3x.
Shared on 12 Mar 25
Fair value Increased 19%AnalystConsensusTarget made no meaningful changes to valuation assumptions.